<eNdOrPhInS>
Greenlighter
Hello,
While technically I am new here, I'm only new to making an account. I have been visiting this forum for years and have learned a great deal of harm reduction and safer techniques of doing things. As well as countless tips and tricks that have proven effective time and time again. I have even come to learn users screen names and am able to distinguish the ones here who hold a great deal of credible knowledge.
I am here to bring attention to the poor quality of the generic orange suboxones made by Amneal pharmacudicals. Not the white tablets with a crescent moon logo, those seem to work just fine. I am talking about the ROUND, ORANGE tablets that are marked "AN415".
I have years of experience with suboxone and got my first script back in 2005, when they were still classified an "IND" (investigational new drug) and nobody had a clue as to what they were. To date, I have come to learn and understand a great deal about buprenorphine and the way it works on the brain. I am a strong supporter of these pills and believe that millions are now able to maintain a better lifestyle with the help of buprenorphine. >snip<
A simple google search of generic suboxone will yield a vast amount of information regarding unsatisfied patients that noticed a change in quality of these tablets so naturally, I did my best to avoid them. I have taken almost all >other< forms of buprenorphine >snip< and have had no problems with them at all. >snip< Guidelines set by the FDA state that a generic product must contain between 80%-125% of the active ingredients in their brand name counter parts. I'm not sure if Amneal even met the 80% mark with these.
A few days ago I obtained these generic orange suboxone tablets for the first time because it was all the pharmacy had and I had no other options at the time to visit another pharmacy that I am registered at. After dosing, I absolutely noticed the difference in quality and I was not happy at all. This was not a placebo effect and not human error. >snip<
I became upset with this company and decided to do some research, >snip< >I am of the opinion< this company is using the absolute lowest level of buprenorphine or even a poorly synthesized compound in their tablets. >If this is the case then it< puts peoples sobriety at risk >snip<
I decided to write them an email and they replied the next day asking for more information. They also would like other patients with similar experiences to come forward. Below I have C&P'd my email and their reply, and as you can see, perhaps they might do something to fix this error. Here are the email addresses I used to write to them-
>snip<
If there is anyone here that is also experiencing lower quality standards with these generic orange suboxones and would like to take part in this complaint, like the email says, then please write to these guys. >taking your time to do this may encourage the company to seriously check it this claim and fix anything that needs to be<
While technically I am new here, I'm only new to making an account. I have been visiting this forum for years and have learned a great deal of harm reduction and safer techniques of doing things. As well as countless tips and tricks that have proven effective time and time again. I have even come to learn users screen names and am able to distinguish the ones here who hold a great deal of credible knowledge.
I am here to bring attention to the poor quality of the generic orange suboxones made by Amneal pharmacudicals. Not the white tablets with a crescent moon logo, those seem to work just fine. I am talking about the ROUND, ORANGE tablets that are marked "AN415".
I have years of experience with suboxone and got my first script back in 2005, when they were still classified an "IND" (investigational new drug) and nobody had a clue as to what they were. To date, I have come to learn and understand a great deal about buprenorphine and the way it works on the brain. I am a strong supporter of these pills and believe that millions are now able to maintain a better lifestyle with the help of buprenorphine. >snip<
A simple google search of generic suboxone will yield a vast amount of information regarding unsatisfied patients that noticed a change in quality of these tablets so naturally, I did my best to avoid them. I have taken almost all >other< forms of buprenorphine >snip< and have had no problems with them at all. >snip< Guidelines set by the FDA state that a generic product must contain between 80%-125% of the active ingredients in their brand name counter parts. I'm not sure if Amneal even met the 80% mark with these.
A few days ago I obtained these generic orange suboxone tablets for the first time because it was all the pharmacy had and I had no other options at the time to visit another pharmacy that I am registered at. After dosing, I absolutely noticed the difference in quality and I was not happy at all. This was not a placebo effect and not human error. >snip<
I became upset with this company and decided to do some research, >snip< >I am of the opinion< this company is using the absolute lowest level of buprenorphine or even a poorly synthesized compound in their tablets. >If this is the case then it< puts peoples sobriety at risk >snip<
I decided to write them an email and they replied the next day asking for more information. They also would like other patients with similar experiences to come forward. Below I have C&P'd my email and their reply, and as you can see, perhaps they might do something to fix this error. Here are the email addresses I used to write to them-
>snip<
If there is anyone here that is also experiencing lower quality standards with these generic orange suboxones and would like to take part in this complaint, like the email says, then please write to these guys. >taking your time to do this may encourage the company to seriously check it this claim and fix anything that needs to be<
MY EMAIL TO THEM-
E
Jun 26 (2 days ago)
to DrugSafety
Your generic version of suboxone is no doubt absolute garbage. Your company must use the lowest formulation standard possible to get these on the market.
Every suboxone patient I have spoke to all say the same about your version of the medication. People are having to double their intake and their sobriety is put at risk >snip<
This is not something as simple as Tylenol or multi-vitamins, this is a life saving pharmaceutical that is helping people remain clean and opiate free. And lets not forget how many families are affected everyday by the devastating effects of opiate addiction, and how many lives are lost by this unfortunate epidemic.
Nobody wants your version of the pill and I encourage everyone I talk to, to tell their doctors to switch them over to >another brand of the drug<
I guarantee that your generic version of suboxone will not last long at all on the market when nobody wants it.
This demonstrates >a need to take seriously these widespread claims<
Once again, I will be sure to urge everyone I know to talk to their doctors about the extreme and noticeable difference with your version of generic suboxone, and do what I can to spread the message as far and wide as possible, because I strongly believe that individuals maintaining a clean and sober life away from opiate addiction is >monumentally< important >snip< .
REPLY EMAIL I GOT FROM THEM
Dear Mr. E
Thank you for your below email correspondence Amneal received on June 27, 2013 reporting your experience of ineffectiveness (product is not good as others), regarding the product Buprenorphine HCl & Naloxone HCl Dihydrate Sublingual Tablets (generic Suboxone).
We would also like to mention here that this product - Buprenorphine HCl & Naloxone HCl Dihydrate Sublingual Tablets are manufactured at our US FDA (Food and Drug Administration) approved facility located in New York, under full current Good Manufacturing Practices in accordance with the product manufacturing instructions along with stringent production and quality control. Amneal’s Buprenorphine HCl & Naloxone HCl Dihydrate Sublingual Tablets product is therapeutically equivalent to the Suboxone Sublingual Tablets (brand). We recommend you to inform your healthcare provider regarding your experience and to discuss/determine the appropriate strength/dosage for your prescription, as it may require and to meet the individual patient needs for your treatment and the drug therapy.
On the basis of this reported information, we are initiating an adverse drug event report and are proceeding accordingly as per our requirements. Therefore, we are kindly requesting you to further provide us with the following information:
- Product Information – (any if available with you): “mg” strength of the product, imprints on the tablets, name and contact information for the dispensing pharmacy, date the prescription was filled, prescription number, and your permission for Amneal to contact your dispensing pharmacy for further product information such as, NDC number, lot number and expiration date associated with the prescription. This information will facilitate the completion of this investigation. Should this information is available with you, please advice us accordingly.
- Product Sample availability Information: Please advise whether you have a sample of the product in question available with you and the likelihood of providing us with a sample, since we would like to have them tested by our quality control laboratory. Please notify us accordingly whether or not a sample can be provided. If available for return, we will provide a FedEx prepaid mailer to your mailing address (please provide information of such) for this return.
- We are also kindly requesting some basic information about yourself – age, date of birth, weight, race, existing medical conditions (if any), and list of medical products taking (if any), any smoking habits, alcohol use, and any recreational drug use. Please inform us the date started the prescription and the date stopped taking the prescription (if applicable), along with the indication this drug was prescribed for you. Please provide the date (approximate time period if exact date is unknown) when started noticing the problem. In addition and for your convenience, we are enclosing the “adverse drug experience information” form for your completion.
Further, you had also indicated in the below email (see highlighted information below) regarding other Suboxone patient(s) where they had similar experience like you with the product - Buprenorphine HCl & Naloxone HCl Dihydrate Sublingual Tablets. Therefore, if these patient(s) are known to you, we are kindly requesting either obtain their consent in order to release their name and contact information to Amneal so that we can directly coordinate with them in obtaining further information (as mentioned above) pertaining to this report and also availability of a sample of the product. You can also provide our direct contact information (see email signature for contact details) to these patient(s) as well and if they prefer they can contact us directly.
Any information provided to this file will be handled with confidentiality as per the regulations and will assist us to effectively complete this investigation and file a MedWatch report to the Food and Drug Administration. If you prefer to provide the information via phone instead of completing the attached form, we can be reached via phone: (631) 656-5063, fax: 631.656.7573 or you can reply to this email.
If you have an easy internet access we would encourage you to please visit the BTOD REMS website at www.btodrems.com which provides detailed information on the BTOD REMS program and documents that you can download for your use. You can also our website www.amneal.com and search for this product in the product catalog where you would be able to gather more information along with the product labeling information for Buprenorphine HCl & Naloxone HCl Dihydrate Sublingual Tablets.
Upon completion of this report, a response letter will be sent to your attention with the findings of this investigation.
Thank you for bringing this matter to our attention and we apologize for any inconvenience. Should you have any further questions or concerns, please do not hesitate to contact us.
Sincerely,
Shweta G. Sharma | Drug Safety Specialist | Amneal Pharmaceuticals of NY, LLC |
[email protected]
Last edited by a moderator: